Global Genomic Biomarkers Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Genomic Biomarkers Revenue
• 1.4 Market by Type
  • 1.4.1 Global Genomic Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oncology
  • 1.4.3 Cardiovascular diseases
  • 1.4.4 Neurological diseases
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Genomic Biomarkers Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostic and research laboratories
  • 1.5.3 Hospitals
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Genomic Biomarkers Market Perspective (2015-2026)
• 2.2 Global Genomic Biomarkers Growth Trends by Regions
  • 2.2.1 Genomic Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Genomic Biomarkers Historic Market Share by Regions (2015-2020)
  • 2.2.3 Genomic Biomarkers Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Genomic Biomarkers Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Genomic Biomarkers Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Genomic Biomarkers Players by Market Size
  • 3.1.1 Global Top Genomic Biomarkers Players by Revenue (2015-2020)
  • 3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Genomic Biomarkers Market Concentration Ratio
  • 3.2.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2019
• 3.3 Genomic Biomarkers Key Players Head office and Area Served
• 3.4 Key Players Genomic Biomarkers Product Solution and Service
• 3.5 Date of Enter into Genomic Biomarkers Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Genomic Biomarkers Historic Market Size by Type (2015-2020)
• 4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Genomic Biomarkers Market Size by Application (2015-2020)
• 5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Genomic Biomarkers Market Size (2015-2020)
• 6.2 Genomic Biomarkers Key Players in North America (2019-2020)
• 6.3 North America Genomic Biomarkers Market Size by Type (2015-2020)
• 6.4 North America Genomic Biomarkers Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Genomic Biomarkers Market Size (2015-2020)
• 7.2 Genomic Biomarkers Key Players in Europe (2019-2020)
• 7.3 Europe Genomic Biomarkers Market Size by Type (2015-2020)
• 7.4 Europe Genomic Biomarkers Market Size by Application (2015-2020)

8 China

• 8.1 China Genomic Biomarkers Market Size (2015-2020)
• 8.2 Genomic Biomarkers Key Players in China (2019-2020)
• 8.3 China Genomic Biomarkers Market Size by Type (2015-2020)
• 8.4 China Genomic Biomarkers Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Genomic Biomarkers Market Size (2015-2020)
• 9.2 Genomic Biomarkers Key Players in Japan (2019-2020)
• 9.3 Japan Genomic Biomarkers Market Size by Type (2015-2020)
• 9.4 Japan Genomic Biomarkers Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Genomic Biomarkers Market Size (2015-2020)
• 10.2 Genomic Biomarkers Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Genomic Biomarkers Market Size by Type (2015-2020)
• 10.4 Southeast Asia Genomic Biomarkers Market Size by Application (2015-2020)

11 India

• 11.1 India Genomic Biomarkers Market Size (2015-2020)
• 11.2 Genomic Biomarkers Key Players in India (2019-2020)
• 11.3 India Genomic Biomarkers Market Size by Type (2015-2020)
• 11.4 India Genomic Biomarkers Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Genomic Biomarkers Market Size (2015-2020)
• 12.2 Genomic Biomarkers Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Genomic Biomarkers Market Size by Type (2015-2020)
• 12.4 Central & South America Genomic Biomarkers Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Thermo Fisher Scientific
  • 13.1.1 Thermo Fisher Scientific Company Details
  • 13.1.2 Thermo Fisher Scientific Business Overview
  • 13.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
  • 13.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2015-2020))
  • 13.1.5 Thermo Fisher Scientific Recent Development
• 13.2 Roche
  • 13.2.1 Roche Company Details
  • 13.2.2 Roche Business Overview
  • 13.2.3 Roche Genomic Biomarkers Introduction
  • 13.2.4 Roche Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.2.5 Roche Recent Development
• 13.3 Aepodia
  • 13.3.1 Aepodia Company Details
  • 13.3.2 Aepodia Business Overview
  • 13.3.3 Aepodia Genomic Biomarkers Introduction
  • 13.3.4 Aepodia Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.3.5 Aepodia Recent Development
• 13.4 Myriad Genetics
  • 13.4.1 Myriad Genetics Company Details
  • 13.4.2 Myriad Genetics Business Overview
  • 13.4.3 Myriad Genetics Genomic Biomarkers Introduction
  • 13.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.4.5 Myriad Genetics Recent Development
• 13.5 Eurofins Scientific
  • 13.5.1 Eurofins Scientific Company Details
  • 13.5.2 Eurofins Scientific Business Overview
  • 13.5.3 Eurofins Scientific Genomic Biomarkers Introduction
  • 13.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.5.5 Eurofins Scientific Recent Development
• 13.6 QIAGEN
  • 13.6.1 QIAGEN Company Details
  • 13.6.2 QIAGEN Business Overview
  • 13.6.3 QIAGEN Genomic Biomarkers Introduction
  • 13.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.6.5 QIAGEN Recent Development
• 13.7 Bio-Rad Laboratories
  • 13.7.1 Bio-Rad Laboratories Company Details
  • 13.7.2 Bio-Rad Laboratories Business Overview
  • 13.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
  • 13.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.7.5 Bio-Rad Laboratories Recent Development
• 13.8 Genomic Health
  • 13.8.1 Genomic Health Company Details
  • 13.8.2 Genomic Health Business Overview
  • 13.8.3 Genomic Health Genomic Biomarkers Introduction
  • 13.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.8.5 Genomic Health Recent Development
• 13.9 Liquid Genomics
  • 13.9.1 Liquid Genomics Company Details
  • 13.9.2 Liquid Genomics Business Overview
  • 13.9.3 Liquid Genomics Genomic Biomarkers Introduction
  • 13.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.9.5 Liquid Genomics Recent Development
• 13.10 Epigenomics
  • 13.10.1 Epigenomics Company Details
  • 13.10.2 Epigenomics Business Overview
  • 13.10.3 Epigenomics Genomic Biomarkers Introduction
  • 13.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2015-2020)
  • 13.10.5 Epigenomics Recent Development
• 13.11 AROS Applied Biotechnology
  • 10.11.1 AROS Applied Biotechnology Company Details
  • 10.11.2 AROS Applied Biotechnology Business Overview
  • 10.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
  • 10.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2015-2020)
  • 10.11.5 AROS Applied Biotechnology Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer